Compile Data Set for Download or QSAR
Report error Found 150 Enz. Inhib. hit(s) with all data for entry = 2462
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367266(US10226464, Compound 34)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367270(US10226464, Compound 37)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367269(US10226464, Compound 36)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367263(US10226464, Compound 31)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367262(US10226464, Compound 30)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367265(US10226464, Compound 33)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367264(US10226464, Compound 32)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367276(US10226464, Compound 43)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367275(US10226464, Compound 42)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367278(US10226464, Compound 45)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367277(US10226464, Compound 44)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367272(US10226464, Compound 39)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367271(US10226464, Compound 38)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367274(US10226464, Compound 41)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367238(US10226464, Compound 8)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367273(US10226464, Compound 40)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367250(US10226464, Compound 18)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367285(US10226464, Compound 52)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367246(US10226464, Compound 15)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367279(US10226464, Compound 46)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367248(US10226464, Compound 17)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367247(US10226464, Compound 16)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367281(US10226464, Compound 48)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367259(US10226464, Compound 27)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367261(US10226464, Compound 29)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367260(US10226464, Compound 28)
Affinity DataIC50: 500nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367267(US10226464, Compound 35)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367300(US10226464, Compound 67)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367299(US10226464, Compound 66)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367302(US10226464, Compound 69)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367301(US10226464, Compound 68)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367296(US10226464, Compound 63)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367295(US10226464, Compound 62)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367298(US10226464, Compound 65)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367297(US10226464, Compound 64)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367241(US10226464, Compound 11)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367308(US10226464, Compound 75)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367240(US10226464, Compound 10)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367307(US10226464, Compound 74)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367243(US10226464, Compound 13)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367242(US10226464, Compound 12)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367304(US10226464, Compound 71)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367236(US10226464, Compound 6)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367303(US10226464, Compound 70)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367306(US10226464, Compound 73)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367305(US10226464, Compound 72)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367251(US10226464, Compound 19)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367284(US10226464, Compound 51)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367283(US10226464, Compound 50)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Immunetarget

US Patent
LigandPNGBDBM367253(US10226464, Compound 21)
Affinity DataIC50: 1.00E+3nMAssay Description:DNA binding reaction (20 μL) was carried out in 1×DNA Binding Buffer (10 mM Tris, 40 mM NaCl, 1 mM EDTA, 4% glycerol) with 10 nM c-Rel protein a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2019
Entry Details
US Patent

Displayed 1 to 50 (of 150 total ) | Next | Last >>
Jump to: